Abstract
Background/Objectives
Serum polyunsaturated fatty acid (PUFA) composition reflects dietary intake and is related to risks for cardiovascular diseases. We hypothesized that serum n-3 PUFA composition, especially including long-chain n-3 PUFA such as eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), is associated with inflammatory status, which is related to increased risk for cardiovascular diseases.
Subjects/Methods
We investigated the relationship between serum PUFA composition and high-sensitivity C-reactive protein (hs-CRP) levels in a cross-sectional study among 1,102 healthy men and women aged 40–74 years who reside in Kobe City. Multiple linear regression models that predict hs-CRP level were prepared to confirm the contribution of serum total n-3 PUFA, long-chain n-3 PUFA, EPA and DHA compositions after adjusting for other PUFAs and atherosclerotic risk factors.
Results
The serum n-3 PUFA, particularly long-chain n-3 PUFA, compositions were inversely associated with the hs-CRP levels. The standardized regression coefficient was −0.089 (p < 0.01) for total n-3 PUFA, −0.091 (p < 0.01) for long-chain n-3 PUFA, −0.071 (p = 0.03) for EPA, and −0.068 (p = 0.04) for DHA. The n-6 PUFA compositions were also inversely associated with the hs-CRP levels (−0.169 [p < 0.01] for total n-6 PUFA and −0.159 [p < 0.01] for linoleic acid).
Conclusions
The serum n-3 PUFA compositions were inversely related with the hs-CRP levels, similar associations were also observed in n-6 PUFA compositions. Our results suggest that dietary PUFA intake was inversely associated with attenuated inflammation in healthy Japanese population.
Similar content being viewed by others
References
Dacks PA, Shineman DW, Fillit HM. Current evidence for the clinical use of long-chain polyunsaturated n-3 fatty acids to prevent age-related cognitive decline and Alzheimer’s disease. J Nutr Health Aging 2013;17:240–51. doi:10.1007/s12603-012-0431-3.
Hu FB, Manson JE, Willett WC. Types of dietary fat and risk of coronary heart disease: a critical review. J Am Coll Nutr 2001;20:5–19.
Harris WS. n-3 fatty acids and serum lipoproteins: human studies. Am J Clin Nutr 1997;65 (5 Suppl):1645S–1654S.
Leaf A, Kang JX, Xiao YF, Billman GE. Clinical prevention of sudden cardiac death by n-3 polyunsaturated fatty acids and mechanism of prevention of arrhythmias by n-3 fish oils. Circulation 2003;107:2646–2652.
Harris WS, Miller M, Tighe AP, Davidson MH, Schaefer EJ. Omega-3 fatty acids and coronary heart disease risk: clinical and mechanistic perspectives. Atherosclerosis 2008;197:12–24.
Thies F, Garry JM, Yaqoob P, Rerkasem K, Williams J et al. Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomised controlled trial. Lancet 2003;361:477–485.
Calder PC. n-3 Fatty acids and cardiovascular disease: evidence explained and mechanisms explored. Clin Sci (Lond). 2004;107:1–11.
Jung UJ, Torrejon C, Chang CL, Hamai H, Worgall TS et al. Fatty acids regulate endothelial lipase and inflammatory markers in macrophages and in mouse aorta: a role for PPAR?. Arterioscler Thromb Vasc Biol 2012;32:2929–2937. doi: 10.1161/ATVBAHA.112.300188
Rangel-Huerta OD, Aguilera CM, Mesa MD, Gil A. Omega-3 long-chain polyunsaturated fatty acids supplementation on inflammatory biomakers: a systematic review of randomised clinical trials. Br J Nutr 2012;107 Suppl 2:S159–170. doi: 10.1017/S0007114512001559
Emerging Risk Factors Collaboration, Kaptoge S, Di Angelantonio E, Lowe G, Pepys MB et al. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet 2010;375:132–140. doi: 10.1016/S0140-6736(09)61717-7.
Iso H, Noda H, Ikeda A, Yamagishi K, Inoue M et al. The impact of C-reactive protein on risk of stroke, stroke subtypes, and ischemic heart disease in middle-aged Japanese: the Japan public health center-based study. J Atheroscler Thromb 2012;19:756–766.
Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 2002;347:1557–1565.
Elliott P, Chambers JC, Zhang W, Clarke R, Hopewell JC et al. Genetic Loci associated with C-reactive protein levels and risk of coronary heart disease. JAMA 2009;302:37–48. doi: 10.1001/jama.2009.954.
Hingorani AD, Sofat R, Morris RW, Whincup P, Lowe GD et al. Is it important to measure or reduce C-reactive protein in people at risk of cardiovascular disease? Eur Heart J 2012;33:2258–64. doi: 10.1093/eurheartj/ehs168.
Hodson L, Skeaff CM, Fielding BA. Fatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary intake. Prog Lipid Res 2008;47:348–380. doi: 10.1016/j.plipres.2008.03.003.
Iso H, Sato S, Folsom AR, Shimamoto T, Terao A et al. Serum fatty acids and fish intake in rural Japanese, urban Japanese, Japanese American and Caucasian American men. Int J Epidemiol 1989;18:374–381.
Sekikawa A, Curb JD, Ueshima H, El-Saed A, Kadowaki T, et al; ERA JUMP (Electron-Beam Tomography, Risk Factor Assessment Among Japanese and U.S. Men in the Post-World War II Birth Cohort) Study Group. Marine-derived n-3 fatty acids and atherosclerosis in Japanese, Japanese-American, and white men: a cross-sectional study. J Am Coll Cardiol 2008;52:417–424. doi:10.1016/j.jacc.2008.03.047.
Higashiyama A, Wakabayashi I, Kubota Y, Adachi Y, Hayashibe A et al. Does high-sensitivity C-reactive protein or low-density lipoprotein cholesterol show a stronger relationship with the cardio-ankle vascular index in healthy community dwellers?: the KOBE study. J Atheroscler Thromb 2012;19:1027–1034.
Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499–502.
Ozawa A, Takayanagi K, Fujita T, Hirai A, Hamazaki T et al. Determination of long chain fatty acids in human total plasma lipids using gas chromatography. Bunseki Kagaku 1982;31:87–91. (in Japanese)
Blaha MJ, Rivera JJ, Budoff MJ, Blankstein R, Agatston A et al. Association between obesity, high-sensitivity C-reactive protein =2 mg/L, and subclinical atherosclerosis: implications of JUPITER from the Multi-Ethnic Study of Atherosclerosis. Arterioscler Thromb Vasc Biol 2011;31:1430–8. doi:10.1161/ATVBAHA.111.223768.
Sekikawa A, Kadowaki T, El-Saed A, Okamura T, Sutton-Tyrrell K, et al. ERA JUMP Study group. Differential association of docosahexaenoic and eicosapentaenoic acids with carotid intima-media thickness. Stroke 2011;42: 2538–43. doi: 10.1161/STROKEAHA.110.613042
Micallef MA, Munro IA, Garg ML. An inverse relationship between plasma n-3 fatty acids and C-reactive protein in healthy individuals. Eur J Clin Nutr 2009;63:1154–1156. doi: 10.1038/ejcn.2009.20.
Kalogeropoulos N, Panagiotakos DB, Pitsavos C, Chrysohoou C, Rousinou G et al. Unsaturated fatty acids are inversely associated and n-6/n-3 ratios are positively related to inflammation and coagulation markers in plasma of apparently healthy adults. Clin Chim Acta 2010;411:584–591. doi: 10.1016/j.cca.2010.01.023.
Pischon T, Hankinson SE, Hotamisligil GS, Rifai N, Willett WC et al. Habitual dietary intake of n-3 and n-6 fatty acids in relation to inflammatory markers among US men and women. Circulation 2003;108:155–160.
James MJ, Gibson RA, Cleland LG. Dietary polyunsaturated fatty acids and inflammatory mediator production. Am J Clin Nutr 2000;71(Suppl): 343S–348S.
De Caterina R. n-3 fatty acids in cardiovascular disease. N Engl J Med 2011;364:2439–50. doi: 10.1056/NEJMra1008153.
Calder PC. n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr 2006;83(6 Suppl):1505S–1519S.
Tomiyama H, Matsumoto C, Odaira M, Yamada J, Yoshida M et al. Relationships among the serum omega fatty acid levels, serum C-reactive protein levels and arterial stiffness/wave reflection in Japanese men. Atherosclerosis 2011;217:433–436. doi: 10.1016/j.atherosclerosis.2011.04.004.
Poudel-Tandukar K, Sato M, Ejima Y, Nanri A, Matsushita Y et al. Relationship of serum fatty acid composition and desaturase activity to C-reactive protein in Japanese men and women. Atherosclerosis 2012;220:520–524. doi: 10.1016/j.atherosclerosis.2011.11.012.
Niu K, Hozawa A, Kuriyama S, Ohmori-Matsuda K, Shimazu T et al. Dietary long-chain n-3 fatty acids of marine origin and serum C-reactive protein concentrations are associated in a population with a diet rich in marine products. Am J Clin Nutr 2006;84:223–229.
Ohsawa M, Itai K, Onoda T, Tanno K, Sasaki S et al. Dietary intake of n-3 polyunsaturated fatty acids is inversely associated with CRP levels, especially among male smokers. Atherosclerosis 2008;201:184–191. doi: 10.1016/j.atherosclerosis.2008.01.008.
Hussein N, Ah-Sing E, Wilkinson P, Leach C, Griffin BA et al. Long-chain conversion of [13C]linoleic acid and alpha-linolenic acid in response to marked changes in their dietary intake in men. J Lipid Res 2005;46:269–280.
Sarkkinen ES, Agren JJ, Ahola I, Ovaskainen ML, Uusitupa MI. Fatty acid composition of serum cholesterol esters, and erythrocyte and platelet membranes as indicators of long-term adherence to fat-modified diets. Am J Clin Nutr 1994;59:364–370.
Harris WS, Mozaffarian D, Rimm E, Kris-Etherton P, Rudel LL et al. Omega-6 fatty acids and risk for cardiovascular disease: a science advisory from the American Heart Association Nutrition Subcommittee of the Council on Nutrition, Physical Activity, and Metabolism; Council on Cardiovascular Nursing; and Council on Epidemiology and Prevention. Circulation 2009;119:902–907. doi: 10.1161/CIRCULATIONAHA.108.191627.
Kaikkonen JE, Kresanov P, Ahotupa M, Jula A, Mikkilä V et al. High serum n6 fatty acid proportion is associated with lowered LDL oxidation and inflammation: the Cardiovascular Risk in Young Finns Study. Free Radic Res 2014;48:420–6. doi: 10.3109/10715762.2014.883071.
Poudel-Tandukar K, Nanri A, Matsushita Y, Sasaki S, Ohta M et al. Dietary intakes of alpha-linolenic and linoleic acids are inversely associated with serum C-reactive protein levels among Japanese men. Nutr Res 2009;29:363–370. doi: 10.1016/j.nutres.2009.05.012.
Yoneyama S, Miura K, Sasaki S, Yoshita K, Morikawa Y et al. Dietary intake of fatty acids and serum C-reactive protein in Japanese. J Epidemiol 2007;17:86–92.
Iso H, Sato S, Umemura U, Kudo M, Koike K et al. Linoleic acid, other fatty acids, and the risk of stroke. Stroke 2002;33:2086–2093.
Czernichow S, Thomas D, Bruckert E. n-6 Fatty acids and cardiovascular health: a review of the evidence for dietary intake recommendations. Br J Nutr 2010;104:788–96. doi: 10.1017/S0007114510002096.
Wang X, Lin H, Gu Y. Multiple roles of dihomo-γ-linolenic acid against proliferation diseases. Lipids Health Dis 2012;11:25. doi: 10.1186/1476-511X-11-25.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kubota, Y., Higashiyama, A., Imano, H. et al. Serum polyunsaturated fatty acid composition and serum high-sensitivity C-reactive protein levels in healthy Japanese residents: The KOBE study. J Nutr Health Aging 19, 719–728 (2015). https://doi.org/10.1007/s12603-015-0497-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12603-015-0497-9